HIPAA Compliance for Insurance AI

Health insurers and health plans are HIPAA covered entities, so any AI that touches protected health information for underwriting, claims or care management must operate under the Privacy and Security Rules and sit behind a Business Associate Agreement with the AI vendor. Insurers and insurtech platforms now run AI across underwriting, pricing, claims and fraud - decisions that directly affect whether a person is covered and at what cost.

HIPAA Privacy + Security Rules applies to covered entities (providers, plans, clearinghouses) and business associates handling protected health information (PHI). Sectoral US law; binds any AI vendor that touches PHI. Its penalty exposure - USD 137 to USD 2,067,813 per violation; criminal up to 10 years (45 CFR 160.404, 42 USC 1320d-6) - and effective timeline (Privacy Rule 2003; Security Rule 2005; HITECH 2009) mean insurers cannot treat AI as out of scope. The data most at stake in this sector includes policyholder personal and financial data, health and, for life and health lines, special-category medical data, actuarial and claims-history datasets and telematics and behavioural data, processed across automated underwriting and risk assessment, dynamic and usage-based pricing, claims triage and automated claims decisions and fraud detection.

Areebi gives insurers a single governed control plane - data-loss prevention, immutable audit logging and policy enforcement - mapped to the HIPAA obligations set out below, with the parent HIPAA guide and Insurance solutions for the wider programme.

The obligations below are the HIPAA requirements most material to Insurance AI, each tied to its source clause. Insurance AI programmes should treat these as the control backbone:

• Transparency + disclosure (45 CFR 164.520): 164.520 requires a Notice of Privacy Practices; no AI disclosure obligation, but FDA guidance applies to clinical AI. For insurers, this bites hardest on opaque underwriting or claims denials the policyholder cannot contest.
• Data handling + minimisation (45 CFR 164.502(b); 164.514): 164.502(b) minimum necessary; 164.514(d) standards; 164.514(b) de-identification; restrictions on training-data use. For insurers, this bites hardest on leakage of health and financial data into ungoverned AI tools.
• Data-subject rights + redress (45 CFR 164.524-528): 164.524-528 grant access, amendment, and accounting of disclosures rights to patients. For insurers, this bites hardest on proxy discrimination and unfair pricing that disadvantages protected groups.
• Audit trail + documentation (45 CFR 164.312(b); 164.530(j)): 164.312(b) audit controls (mechanism to record + examine activity); 164.530(j) 6-year documentation retention. For insurers, this bites hardest on inability to evidence how an automated decision about an individual was reached.
• Risk management process (45 CFR 164.308(a)(1)): 164.308(a)(1)(ii) requires a Risk Analysis and Risk Management process. For insurers, this bites hardest on proxy discrimination and unfair pricing that disadvantages protected groups.

Because these duties are continuous rather than point-in-time, insurers need tooling that produces ongoing evidence - not a one-off assessment.

Areebi maps platform controls to the HIPAA obligations above so insurers can evidence compliance continuously:

• PHI-aware DLP blocks unauthorised disclosures; BAA signed with hosting provider.
• 164.312(b) audit controls satisfied by immutable, 6-year-retainable audit log.
• Per-user access controls with break-glass workflow for 164.312(a) requirements.
• Encryption at rest and in transit (164.312(a)(2)(iv) addressable) on by default.

The same controls address this sector's sharpest risks - proxy discrimination and unfair pricing that disadvantages protected groups and opaque underwriting or claims denials the policyholder cannot contest - by keeping every AI interaction inside an enforced, logged boundary that APRA and ASIC (Australia) and state insurance commissioners and the NAIC (United States) expect to see evidenced.